The Department of Urology at Beaumont encompasses patient care, education and research. Many comprehensive services and programs have also been instituted.
Programs Highlights and Achievements
- Achieving a top-25 ranking among national urology programs in the annual U.S. News and World Report's America's Best Hospitals report
- Establishment of robotic and laparoscopic surgical programs
- Tertiary-care patient services, including experts in all subspecialties of urologic care
- Nationally- and internationally-renowned pediatric urology division
- Clinical research, funded by multi-million dollar grants from government, commercial and philanthropic sponsors
- Urologic education of residents, fellows, urologists, other professionals and consumers
- Creation of the Ministrelli Program for Urology Research and Education (MPURE) supports the research and education infrastructure of the department in perpetuity
- Establishment of the Peter and Florine Ministrelli Distinguished Chair for the Department of Urology
Special Procedures Offered
The Department of Urology encompasses expertise in treatment, state-of-the-art technology, dedication to education, and innovative research.
Doctors and staff provide a full array of urological diagnoses and treatments. Areas of specialization include:
- Male infertility
- Pediatric urology
- Prostate diseases
- Urologic cancers
- Urinary incontinence
- Endourology / laparoscopy / robotics
- Stone disease
- Sexual dysfunction
- Renal transplantation
- Prostheses surgery
- Genital and pelvic reconstruction
Approximately 150 robotic prostatectomies are performed a year by skilled robotic surgeons at Beaumont.
International urologists from such countries as the Philippines, Zambia, Mongolia and the United Kingdom have had fellowships at Beaumont over the years. Often they return to their native countries and provide the Beaumont standards of healthcare to their patients and share their expertise with peers around the world.
Urology research at Beaumont has a distinguished track record for groundbreaking study results. With conclusive research on urinary incontinence, interstitial cystitis, prostate cancer, neuromodulation, urinary devices and erectile dysfunction, Beaumont investigators have made discoveries that directly impact patient care:
- Beaumont urologic investigators contributed to the landmark study on Medical Therapy of Prostatic Symptoms (MTOPS) sponsored by NIH and published in the New England Journal of Medicine.
- A pioneering study demonstrated the feasibility of accessing the pudendal nerve and using miniaturized implantable electrodes in neuromodulating the sacral and pudendal nerves to improve both urge incontinence and other voiding dysfunctions.
- The first randomized, controlled study on prevention of urinary incontinence in elderly women provided evidence that group sessions to teach behavioral modification programs are effective.
- During an epidemiology study, Beaumont investigators confirmed that urinary incontinence is a highly prevalent condition throughout the community in the United States. This study resulted in readiness programs for caregivers and health-care providers as well as action from government agencies to prepare, approach and manage urinary incontinence in the United States. By working closely with the National Institute of Diabetes & Digestive & Kidney Disease, Beaumont researchers participate in cooperative trials on interstitial cystitis and urinary incontinence.
- Nerve Re-routing. Beaumont Hospitals launched a research study to "rewire" nerves in the spinal cord in the hope of giving bladder control to people with spinal cord injury or spina bifida who otherwise depend on self-catheterization to urinate. The first procedure garnered national attention and appeared in more than 160 news outlets including U.S.News & World Report, The Washington Post and Forbes. Beaumont is the only institution in the United States to perform this procedure and also provide funding for all the associated costs.
The research at Beaumont uses nerve rerouting to redirect nerves in the spinal cord to gain better control of urination. After the procedure, patients signal the bladder to urinate by scratching or pinching their leg or buttocks. The Chinese doctor who developed the surgery, Chuan-Guo Xiao, M.D., reports an almost 90-percent success rate. The average time it took to see results was 12 to 24 months after surgery, with patients in China reporting better urinary control and improvements in their bowel function.
The surgical team working with Dr. Xiao at Beaumont includes Ananias Diokno, M.D., executive vice president and chief medical officer; Kenneth Peters, M.D., chairman of Beaumont's Urology Department; and Jose Gonzalez, M.D., Urology.
Eight additional surgeries were performed in April 2007 for seven children and one adult. All of the patients have spina bifida. All but one patient comes from out-of-state - some come from as far as Utah and Georgia.
Adult Stem Cell Study for Stress Urinary Incontinence. Beaumont Hospital urologists are first in the United States to research stress urinary incontinence treatment using a person’s own stem cells. The stem cells are used to strengthen weak muscles that control urination.
If successful, (autologous) muscle-derived stem cell therapy could offer new hope to people and offer them a life free of urinary leakage,” says Dr. Peters, who is leading the research at Beaumont.
Stress urinary incontinence – the cause of wetness with coughing or physical activity – affects about 13 million Americans, most of them women, but also men who have had a prostatectomy (surgery for prostate cancer). Current treatments, including medicine, exercises and surgery, are not always effective and may have undesirable side effects. The stem cells from 48 female research participants age 18 or older will be collected at Beaumont Hospital, Royal Oak, and duplicated. The cells will then be injected into the muscles that control urination to strengthen them and prevent leakage.
As one of the busiest urology research programs, Beaumont is highly successful at recruiting and retaining patients for studies. With the average enrollment for urological studies around 100 patients, Beaumont has the capacity, expertise and infrastructure to complete large studies.